Kai-Fu Lee's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (5)
Aging is the single largest risk factor for most chronic diseases, and thus possesses large socioeconomic interest to continuously aging societies. Consequently, the field of aging research is expanding alongside a growing focus from the industry and investors in aging research. This year's 8th Annual Aging Research and Drug Discovery (ARDD) meetin...
The positive coexistence of humans and AI is possible and needs to be designed as a system that provides for all members of society, but one that also uses the wealth generated by AI to build a society that is more compassionate, loving, and ultimately human. It is incumbent on us to use the economic abundance of the AI age to foster the values of...
Recent advances in deep learning enabled the development of AI systems that outperform humans in many tasks and have started to empower scientists and physicians with new tools. In this Comment, we discuss how recent applications of AI to aging research are leading to the emergence of the field of longevity medicine.
Aging is emerging as a druggable target with growing interest from academia, industry and investors. New technologies such as artificial intelligence and advanced screening techniques, as well as a strong influence from the industry sector may lead to novel discoveries to treat age-related diseases. The present review summarizes presentations from...
Citations
... It is the gut microbial metabolites which link the microbiota and the immune system and modulate various aspects of immune cell function through a plethora of mechanisms [2,3]. Gut microbial dysbiosis has been associated with various pathologies such as cancer, infectious diseases, ageing, obesity, and more recently the gut microbial changes pertaining to female health issues are beginning to come to light [4][5][6][7]. Given that there is a dearth of studies on females, future studies to understand gut microbial changes during menopause, pregnancy, menstruation, osteoarthritis, and cancer are warranted. ...
... At the same time, it has become painfully evident that not all of the gained extra years are healthy: estimates have shown that the proportion of life characterized by good health has remained rather constant between 1990 and 2019 [17], implying that most of the life years gained are lived largely in poor health [12]. As pointed out by Olshansky [18], this leads to a situation where a significant portion of the lifespan is lived during a window of exponentially increasing risk of frailty and chronic disability (Figure 1), with the simultaneous manifestation of many chronic conditions as late life comorbidities [16,19,20]. Therefore, there is an increasing understanding of the importance of so-called "healthy aging" (healthy aging refers to the "healthspan", which is a period of life free from serious chronic diseases and disability [21]. ...
... Owing to the consistently increasing size of the aging population worldwide, the number of elderly patients is increasing. [19,20] Elderly patients comprise a special population owing to their limited tolerance to treatment and poor prognosis. Basic research is urgently needed to uncover the molecular mechanisms of tumorigenesis and the progression of NSCLC in elderly patients. ...